Scott Brun

Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

Sharon Walmsley, Barry Bernstein, Martin King et al. · New England Journal of Medicine · 2002 · 647 citations

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results

Robert L. Murphy, Scott Brun, Charles B. Hicks et al. · AIDS · 2001 · 238 citations

Incidence of Resistance in a Double‐Blind Study Comparing Lopinavir/Ritonavir Plus Stavudine and Lamivudine to Nelfinavir plus Stavudine and Lamivudine

Dale J. Kempf, Martin King, Barry Bernstein et al. · The Journal of Infectious Diseases · 2004 · 221 citations · Full text

Pharmacokinetic-Pharmacodynamic Analysis of Lopinavir-Ritonavir in Combination with Efavirenz and Two Nucleoside Reverse Transcriptase Inhibitors in Extensively Pretreated Human Immunodeficiency Virus-Infected Patients

Ann Hsu, Jeffrey D. Isaacson, Scott Brun et al. · Antimicrobial Agents and Chemotherapy · 2002 · 149 citations · Full text

Phase Ii, Pharmacology, Quantitative Pharmacology +13

Selection of Resistance in Protease Inhibitor-Experienced, Human Immunodeficiency Virus Type 1-Infected Subjects Failing Lopinavir- and Ritonavir-Based Therapy: Mutation Patterns and Baseline Correlates

Hongmei Mo, Martin King, Kathryn King et al. · Journal of Virology · 2005 · 91 citations · Full text

Longitudinal Isolates, Genetics, Pathogenesis +14